Invitae Azione

Invitae ROIC

Delisted·7 ago 2024

Ritorno sul Capitale Investito (ROIC) di Invitae (NVTAQ) al 16 ago 2026.

ROIC

0,00

Ultimo aggiornamento:

Ritorno sul Capitale Investito (ROIC) di Invitae ammonta a 2026 0,00 . Ritorno sul Capitale Investito (ROIC) di Invitae ammontava a 2025 -182,31 % . Diminuisce del % superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Invitae Analisi delle Azioni

Cosa fa Invitae? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Invitae azioni

Su Eulerpool è possibile consultare lo sviluppo storico completo del Invitae di Ritorno sul Capitale Investito (ROIC) dal 2006, con valori annuali, grafici e analisi dettagliate.

Il ROIC misura l'efficienza con cui un'azienda utilizza il capitale investito per generare profitti. Un ROIC superiore al costo del capitale crea valore per gli azionisti.

ROIC = NOPAT / Capitale Investito

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Invitae di Ritorno sul Capitale Investito (ROIC) con i competitor del settore e la media industriale per valutare se è attraente.

Per valutare di Ritorno sul Capitale Investito (ROIC), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per Ritorno sul Capitale Investito (ROIC).

Access this data via the Eulerpool API

Redditività — Invitae

Tutte le Metriche Finanziarie — Invitae